Lupus anticoagulant (LA) is part of a heterogenous autoantibody family targeting negatively charged phospholipids (PL) in complex with such proteins as prothrombin, β2-glycoprotein-I (β2-GP-I), and others [1]. This evidence concerns the gene F2 and systemic lupus erythematosus.